Error: Could not add to watchlist. X
+ Watchlist

Keryx Biopharmaceuticals Inc

KYX:GR
Frankfurt
5.28
EUR
0.02
0.38%
As of 9:34 AM EDT 5/25/2016
Open
5.20
Day Range
5.20 - 5.43
Volume
0
Previous Close
5.26
52Wk Range
2.00 - 9.68
1 Yr Return
-42.99%
Open
5.20
Day Range
5.20 - 5.43
Volume
0
Previous Close
5.26
52Wk Range
2.00 - 9.68
1 Yr Return
-42.99%
YTD Return
12.53%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
558.735
Shares Outstanding (m)
105.821
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.
Address
750 Lexington Avenue
New York, NY 10022
United States
Phone
1-212-531-5965
Show More